Pharmafile Logo
Pharmafocus logo
Advanced Search

New group blames PBM’s and hospitals for rising drug prices

October 4, 2018
Medical Communications, Sales and Marketing Alliance to Protect Medical Innovation, Drug pricing, PhRMA, Trunmp, aha, pharma

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …

News
baxter

Baxter partners up with Mayo Clinic for new “centre of exellence” in renal care

October 4, 2018
Research and Development Mayo Clinic, baxter, kidney disease, pharma, renal

American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …

News

Survey reveals 56% gender pay gap between doctors in NHS

October 4, 2018
Medical Communications NHS, UK, brexit, doctors, pay gap

Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …

News

Lilly’s Verzenio gets first-line EU approval for HER2- advanced breast cancer

October 3, 2018
Research and Development, Sales and Marketing Cancer, Eli Lilly, Verzenio, breast cancer, pharma

The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …

News
5204602349_c87b204860_z

FDA cracks down on e-cig maker Juul in surprise inspection

October 3, 2018
Research and Development FDA, e-cig, juul, surprise inspection, us San Francisco

The US FDA have launched a surprise inspection of e-cigarette maker Juul’s corporate headquarters in San Francisco, having seized thousands …

News

Novartis forge deal with Boston Pharmaceuticals in effort against AMR

October 3, 2018
Research and Development AMR, Antibiotics, Boston Pharmaceuticals, Novartis, US

Swiss multinational Novartis have entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel …

News

Memorial Sloan Kettering Chief resigns from MSD board

October 3, 2018
Research and Development MSD, Memorial Sloan Kettering Cancer Center, pharma

Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …

News
4768764591_9e4f7f0eb8_z

Clinical trial halted because of Brexit, UK Government downplays concerns

October 3, 2018
Research and Development UK, brexit, clinical trials, politics, research

A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …

News
shutterstock_243110086

No link between progression-free survival benefits and improved quality of life, study argues

October 2, 2018
Manufacturing and Production, Research and Development Cancer, clinical trials, pharma

A study of randomised clinical trials, conducted by Canada’s McMaster University and published in the Journal of the American Medical …

News
shutterstock_114045100

African-American enrollment disproportionately high in no-consent trials

October 2, 2018
Manufacturing and Production, Research and Development FDA, clinical trials, pharma, transparency

A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …

News
acute_lymphoblastic_leukaemia_smear

20 year old man died after leukaemia cell was accidently mixed into CAR T therapy

October 2, 2018
Manufacturing and Production CAR T, CAR-T, Cancer, Kymriah, Novartis, leukaemia, oncology

A 20 year old man died after a single leukaemia cell accidentally ended up in a batch of cells that …

News
12308739253_f11096e120_b

Nobel Prize awarded to immuno-oncology innovators

October 2, 2018
Manufacturing and Production Cancer, Nobel Prize, immunotherapy, kyoto, oncology, texas

The Nobel Prize for physiology or medicine has been awarded to both Professor James P Allison and Tasuku Honjo for …

News
ianread

Pfizer CEO Ian Read set to step down from head position

October 1, 2018
Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

News
shutterstock_235920349

Are biosimilars key to solving NHS access concerns?

October 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Pfizer, UK, biosimilars, celltrion, pharma

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …

Feature

European countries unprepared for Alzheimer’s innovations, study shows

October 1, 2018
Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …

News
nhs_sign

NHS England to fund availability of Janssen’s single tablet HIV combo Symtuza

October 1, 2018
Sales and Marketing HIV, Janssen, NHS, Symtuza, pharma

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …

News
novo_nordisk_flag

Novo Nordisk cuts 650 roles around the world in R&D restructure

October 1, 2018
Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …

News
800px-t_lymphocyte_16760076824

Antibody therapy supresses HIV for months after treatment, study shows

October 1, 2018
Sales and Marketing HIV, immunology, immunotherapy, nature, research

Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …

News

Roche acquires immuno-oncology biotech Tusk in €655m deal

October 1, 2018
Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …

News
mcewan

Ipsen appoints two leading R&D experts in bid to strengthen oncology arm

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …

Appointment
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026